Blood pressure lowering products launched
The blood pressure-lowering mechanism of Evolus products is based on bioactive peptides and a beneficial mineral composition.
Valio’s licensed Evolus products have been launched in Spain and Portugal, promoted as functional dairy products developed for lowering elevated blood pressure.
The products are made locally and marketed under the Kaiku Vita brand in Spain, while the Emmi Evolus products for the Portuguese market are made in Switzerland.
The blood pressure-lowering mechanism of Evolus products is based on bioactive peptides and a beneficial mineral composition. The Evolus product effect of lowering blood pressure has been verified in 3 experimental studies and 4 clinical studies. Valio developed and patented the unique Evolus production method.
Valio Ltd licenses the Evolus technology that drives these innovative products, which have been available in the Finnish company’s domestic market since the year 2000, and were launched in Iceland in 2003.
Elevated blood pressure is one of the most significant factors associated with the risk of cardiovascular diseases and exposes those affected to cerebral haemorrhage, causes cardiovascular changes, and increases the risk of renal injury. Elevated blood pressure is a significant public health problem and Evolus products have been developed to help as part of a varied diet.
